Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report

Philadelphia chromosome‐positive acute myeloid leukemia (Ph + AML) is a rare type of AML with a low survival rate and poor prognosis. We first report a Ph + AML patient who remained in long‐term remission after the combination of flumatinib and venetoclax, which could provide corresponding treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Si‐Man, Tao, Tao, Wan, Chao‐Ling, Wu, Tian‐Mei, Cao, Han‐Yu, Qiu, Yan, Shen, Xiang‐Dong, Wang, Bin‐Ru, Ge, Shuai‐Shuai, Li, Yan‐Yan, Zhang, Tong‐Tong, Wu, Bing, Xue, Sheng‐Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810787/
https://www.ncbi.nlm.nih.gov/pubmed/36619491
http://dx.doi.org/10.1002/ccr3.6688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810787/
https://www.ncbi.nlm.nih.gov/pubmed/36619491
http://dx.doi.org/10.1002/ccr3.6688

Ejemplares similares